Article Data

  • Views 398
  • Dowloads 150

Case Reports

Open Access

Metastatic squamous cell carcinoma of the cervix: complete response under maintenance strategy with bevacizumab

  • F. Lai-Tiong1,*,

1Oncology Unit Gard Cancer Institute, Nîmes (France)

DOI: 10.12892/ejgo4002.2018 Vol.39,Issue 5,October 2018 pp.828-829

Published: 10 October 2018

*Corresponding Author(s): F. Lai-Tiong E-mail:


Cervical carcinoma is a common cancer. Metastatic disease will develop in 15% to 61% percent women, usually within the first two years of completing treatment. We present a case of a 56-year-old patient with a Stage IIIB carcinoma of the cervix, treated with chemoradiation, brachytherapy and surgery. Nine months after completion of primary treatment, she presented with latero-aortic metastatic adenomegalies. She received six courses of chemotherapy carboplatin+paclitaxel+bevacizumab, followed by maintenance by bevacizumab. After ten months of bevacizumab and three years after the diagnosis, the patient is alive, without further evidence of disease.


Cervical cancer; Cervix; Maintenance strategy; Bevacizumab.

Cite and Share

F. Lai-Tiong. Metastatic squamous cell carcinoma of the cervix: complete response under maintenance strategy with bevacizumab. European Journal of Gynaecological Oncology. 2018. 39(5);828-829.


[1] Siegel R., Ma J., Zou Z., Jemal A.: “Cancer statistics, 2014”. CA Cancer J. Clin., 2014, 64, 9.

[2] Thigpen T., Shingleton H., Homesley H., Lagasse L., Blessing J.: “Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of cervix: a phase II study of the Gynecologic Oncology Group”. Cancer, 1981, 48, 899.

[3] Wright J.D., Viviano D., Powel M.A., Gibb R.K., Mutch D.G., Grigsby P.W., Rader J.S.: “Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer”. Gynecol. Oncol., 2006, 103, 489.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time